Researchers at the University of Glasgow have developed the first bioengineered human bone-marrow model to test CAR T-cell therapies for acute myeloid leukaemia, offering a more accurate, non-animal testing platform.
From the stories appearing about CBD and its near miraculous effects, to the pharmaceutical companies rushing to catch up, it seems everyone is taking about cannabidiol.
Momoko Takahashi, a Doctoral Student at Northwestern University, explains the complex research of neurotrophin signalling in the nervous system in this report.
The NYU Sackler Institute of Graduate Biomedical Sciences aims to train the next generation of scientists to make breakthroughs and advances in society at large, explains Naoko Tanese.
The restriction or inhalation of common sugar could one day treat a range of respiratory diseases, according to new research led by University of Manchester biologists.
A group of seasoned experts from the International Society for Biological and Environmental Repositories explain the notion of employing “living biobanks” to advance the field of biomedical research.
Around 1 in 15 people affected by Tuberculosis (TB) are likely to get the treatable fungal infection Aspergillosis, according to TB research by The University of Manchester and Gulu Referral Hospital, Uganda.
Prof. Regina Fluhrer from LMU & DZNE and Professor Bernd Schröder from TU Dresden discuss how intramembrane proteases contribute to the development of immune cells.
Researchers at the Royal College of Surgeons (RCSI) in Ireland have found new genes linked to epilepsy which could inform the development of new treatments for the condition
Andreas Prokop, Head of the Manchester Fly Facility, explains how fruit fly research generates knowledge important for understanding many human diseases
Michael F. Huerta from the National Library of Medicine at the U.S.’s National Institutes of Health explores how discovery and health benefit from the intersection of data science and open science
Researchers at Cleveland Clinic in the United States have designed a potential new class of drugs that may reduce cardiovascular diseases by targeting a specific microbial pathway in the gut.
Professor Tanese of the New York University School of Medicine discusses Huntington’s disease
Mutation in the huntingtin gene causes Huntington’s disease, a heritable and fatal neurodegenerative...
Professor Michael Roth from the Department Biomedicine & Pneumology, at the University Hospital Basel, discusses development of medication for asthma and new asthma therapies.
Asthma is the most...
Frédéric Destrebecq, Vinciane Quoidbach and Marijn Scholte from The European Brain Council (EBC) detail how the future of healthcare and improved brain health can...
